While we are waiting for the IND approval by the FDA, it's worth appreciating who we have guiding PYC.
In January the Galien foundation appointed Dr Rosenblatt (a director on PYC's board) as chairman of Prix Galien USA awards committee. In gaining this position, it shows the esteem and standing Dr Rosenblatt is held in academia and industry.
Check out the link:
https://www.prnewswire.com/news-releases/the-galien-foundation-appoints-michael-rosenblatt-md-as-chairman-of-prix-galien-usa-awards-committee-301714290.html
While we are waiting for the IND approval by the FDA, it's worth...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.020(1.77%) |
Mkt cap ! $670.7M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.18 | $1.11 | $172.3K | 151.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 592 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 4211 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |